The Moat Index
Compare moats, side by side.
Two to four companies, scored on the same five investor questions from their SEC filings — so the comparison is apples to apples. The method is fully public.
NVAX · Healthcare · Narrow moat
On the watchlist
The returnsOnCapital component abstained: Not enough years of ROIC data to score returns on capital. The other four 20% weights were renormalized over the scored 80%.
| Measure | NVAX | INFU | DCTH | NAGE |
|---|---|---|---|---|
| Moat Score (0–100) | 62 (highest) | 62 (highest) | 62 (highest) | 62 (highest) |
| Methodology version | moat-index@3.0.0 | moat-index@3.0.0 | moat-index@3.0.0 | moat-index@3.0.0 |
| Business trend | 54 | 93 (highest) | 70 | 85 |
| Pricing power | 76 | 66 | 94 (highest) | 91 |
| Returns on capital | — | 4 | 0 | 8 (highest) |
| Balance-sheet safety | 73 | 64 | 100 (highest) | 100 (highest) |
| Capital allocation | 44 | 83 (highest) | 44 | 24 |
| No price data | 82% above value if growth stopped today | No price data | No price data | |
| Market cap | $1.8B | $278M | $499M | $199M |
| Moat tier | Narrow moat | Narrow moat | Narrow moat | Narrow moat |
| Filing date | FY2025 | FY2025 | FY2025 | FY2025 |